Anzeige
Mehr »
Dienstag, 16.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
429 Leser
Artikel bewerten:
(2)

EQS-News: Sheng Ye Capital Launches Strategic Partnership with Xiaomi Factoring, Accelerating Supply Chain Digitalization and Inclusive Finance for the Medical Sector

EQS-News / 17/09/2020 / 18:03 UTC+8 
 
                                                             [Press Release] 
 
   Sheng Ye Capital Launches Strategic Partnership with Xiaomi Factoring, 
   Accelerating Supply Chain Digitalization and Inclusive Finance for the 
                               Medical Sector 
 
   Hong Kong, September 17, 2020 - Sheng Ye Capital Limited ("SY Capital" or 
      the "Company", HKEx: 6069), China's first commercial factoring company 
 listed on the main board of the Hong Kong Stock Exchange, announced that it 
    signed a strategic partnership agreement for the refactoring of accounts 
receivables in the medical sector with Xiaomi Commercial Factoring (Tianjin) 
Co., Ltd. ("Xiaomi Factoring"), a wholly-owned subsidiary of Xiaomi Finance. 
  The partnership will leverage supply chain fintech capabilities to empower 
      small, medium and micro enterprises ("SMEs") in the medical sector and 
     promote greater stability of the pharmaceutical supply chain during the 
                                                          COVID-19 pandemic. 
 
    The medical sector has been one of the focused industries of SY Capital. 
  Over the past 6 years, the Company accumulated a large volume of real-time 
transaction data and developed deep industry knowledge of the pharmaceutical 
     distribution sector, allowing SY Capital to use its robust digital risk 
    control systems to provide effective and tailored financing solutions to 
       medical suppliers. In addition, as a leading independent supply chain 
  fintech platform, SY Capital recently secured US$50 million credit funding 
 from Dignari Capital Partners, followed by a top-up placement that of US$50 
million from internationally renowned investors. The partnership with Xiaomi 
Factoring will further enhance SY Capital's ability to provide strong supply 
chain financing support to SME medical suppliers and promote steady economic 
                                          growth in the post-pandemic world. 
 
Xiaomi Factoring is a wholly-owned subsidiary of Xiaomi Finance which is the 
  fintech arm of the Fortune 500 technology giant Xiaomi Group (HKEx: 1810). 
 Leveraging Xiaomi's ecosystem, Xiaomi Finance provides a suite of financing 
     solutions, including supply chain finance, fintech, consumer credit and 
         third-party payment services and continues to grow its supply chain 
                                                         financing business. 
 
     The strategic refactoring cooperation with Xiaomi Factoring is a strong 
             testament from a leading fintech player to SY Capital's fintech 
      capabilities, big data-driven risk management technologies and quality 
  accounts receivable assets. Since inception, SY Capital has focused on the 
  infrastructure, medical and energy sectors, three industries that are more 
    resilient to economic cycles. The Company has also established strategic 
           partnerships with large blue-chip enterprises to achieve in-depth 
      cross-industry expertise. By leveraging transaction data from multiple 
  channels to cross-validate transaction authenticity, SY Capital is able to 
convert transaction data sets into actionable credit scores and provide high 
    quality suppliers across the supply chain with effective and diversified 
    supply chain financing solutions. SY Capital leveraged its technological 
       capabilities and achieved impressive results. As of June 30 2020, the 
           Company successfully transferred more than RMB90 billion accounts 
receivables while maintaining a non-performing loan ratio of zero and a loan 
               extension rate of less than 1% during the first half of 2020. 
 
  This partnership will allow the two companies to leverage their respective 
core competencies in supply chain financing and fintech solutions to jointly 
develop a digital supply chain financing platform for the medical sector, in 
   an effort to support the healthy development of the medical supply chain, 
    while providing efficient and inclusive financial services to more SMEs. 
 
                                  - END - 
 
                                 About Sheng Ye Capital Limited (HKEx: 6069) 
 
      Sheng Ye Capital Limited ("Sheng Ye Capital", HKEx: 6069) is a leading 
    data-driven supply chain financial services provider in China and is the 
first commercial factoring company listed on the main board of the Hong Kong 
  Stock Exchange. Powered by fintech capabilities and in-depth understanding 
         of the core industries, Sheng Ye Capital offers a range of flexible 
  financing products and corporate services to meet the vast financing needs 
 of underserved SMEs in the region. Sheng Ye Capital aims to become the most 
                 reliable data-driven supply chain fintech platform in Asia. 
 
  Sheng Ye Capital has been included in the MSCI small cap China Index, Hang 
      Seng Composite Index and Shenzhen-Hong Kong Stock Connect. The current 
            market cap of Sheng Ye Capital is around HK$5 billion. Its major 
  institutional investors include Olympus, China Taiping, and Pavilion under 
                                                                    Temasek. 
 
                                                               Media Contact 
 
                                                    Sheng Ye Capital Limited 
 
                                                                Kaylee Zhang 
 
                                                     Tel: 0755-6188 0088-842 
 
                                      Email: kaylee.zhang@shengyecapital.com 
 
                                                   Christensen China Limited 
 
                                                                Shirley Chan 
 
                                                         Tel: +852 2232 3933 
 
                                              Email: schan@christensenir.com 
 
17/09/2020 Dissemination of a Marketing Press Release, transmitted by EQS 
Group. 
The issuer is solely responsible for the content of this announcement. 
 
Media archive at www.todayir.com 
 

(END) Dow Jones Newswires

September 17, 2020 06:03 ET (10:03 GMT)

© 2020 Dow Jones News
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.